Genetic Landscape of Chronic Myeloid Leukemia and a Novel Targeted Drug for Overcoming Resistance

por Yoshimaru, Ryo, Minami, Yosuke
Publicado 2023

Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment

por Terao, Toshiki, Minami, Yosuke
Publicado 2019

Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01

por Miyamoto, Kenichi, Minami, Yosuke
Publicado 2019

Cutting Edge Molecular Therapy for Acute Myeloid Leukemia

por Miyamoto, Kenichi, Minami, Yosuke
Publicado 2020

Emerging Targeted Therapy for Specific Genomic Abnormalities in Acute Myeloid Leukemia

por Chi, Sung-Gi, Minami, Yosuke
Publicado 2022

Prediction of the level of consciousness using pupillometer measurements in patients with impaired consciousness brought to the emergency and critical care center

por Minami, Yosuke, Mishima, Shiro, Oda, Jun
Publicado 2020

The Immuno-Oncology and Genomic Aspects of DNA-Hypomethylating Therapeutics in Acute Myeloid Leukemia

por Urabe, Akiko, Chi, SungGi, Minami, Yosuke
Publicado 2023

Immune-Checkpoint Blockade Therapy in Lymphoma

por Kuzume, Ayumi, Chi, SungGi, Yamauchi, Nobuhiko, Minami, Yosuke
Publicado 2020

Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia

por Eguchi, Motoki, Minami, Yosuke, Kuzume, Ayumi, Chi, SungGi
Publicado 2020

Emerging Immunotherapy for Acute Myeloid Leukemia

por Tabata, Rikako, Chi, SungGi, Yuda, Junichiro, Minami, Yosuke
Publicado 2021

Molecular remission after combination therapy with blinatumomab and ponatinib with relapsed/refractory Philadelphia chromosome-positive acute lymphocytic leukemia: two case reports

por Yuda, Junichiro, Yamauchi, Nobuhiko, Kuzume, Ayumi, Guo, Yong-Mei, Sato, Nobue, Minami, Yosuke
Publicado 2021

Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia

por Arai, Hironori, Minami, Yosuke, Chi, SungGi, Utsu, Yoshikazu, Masuda, Shinichi, Aotsuka, Nobuyuki
Publicado 2022

Potent antiproliferative effect of fatty‐acid derivative AIC‐47 on leukemic mice harboring BCR‐ABL mutation

por Shinohara, Haruka, Sugito, Nobuhiko, Kuranaga, Yuki, Heishima, Kazuki, Minami, Yosuke, Naoe, Tomoki, Akao, Yukihiro
Publicado 2019

Patients with B-cell malignancies experience reduced antibody responses with class switching defect following BNT162b2 SARS-CoV-2 vaccination

por Nakagama, Yu, Chi, Sung-Gi, Minami, Yosuke, Watanabe, Reiko, Yamagishi, Michiteru, Atsuko, Uno, Kido, Yasutoshi
Publicado 2023

Functionally Deregulated AML1/RUNX1 Cooperates with BCR-ABL to Induce a Blastic Phase-Like Phenotype of Chronic Myelogenous Leukemia in Mice

por Yamamoto, Kiyoko, Tsuzuki, Shinobu, Minami, Yosuke, Yamamoto, Yukiya, Abe, Akihiro, Ohshima, Koichi, Seto, Masao, Naoe, Tomoki
Publicado 2013

Small‐molecule Hedgehog inhibitor attenuates the leukemia‐initiation potential of acute myeloid leukemia cells

por Fukushima, Nobuaki, Minami, Yosuke, Kakiuchi, Seiji, Kuwatsuka, Yachiyo, Hayakawa, Fumihiko, Jamieson, Catoriona, Kiyoi, Hitoshi, Naoe, Tomoki
Publicado 2016

Gilteritinib Affects the Selection of Dominant Clones in Clonal Hematopoiesis: Sequential Genetic Analysis of an FLT3-ITD Positive AML Patient with Long-Term Gilteritinib Therapy

por Katagiri, Seiichiro, Furuya, Nahoko, Akahane, Daigo, Chi, SungGi, Minami, Yosuke, Harada, Yuka, Harada, Hironori, Gotoh, Akihiko
Publicado 2023

Brentuximab vedotin maintenance after autologous stem cell transplantation for refractory gray zone lymphoma with long-term remission

por Terao, Toshiki, Yuda, Junichiro, Yamauchi, Nobuhiko, Guo, Yong-Mei, Shimada, Kaoru, Sugano, Masato, Ishii, Genichiro, Minami, Yosuke
Publicado 2021

Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors

por Ikeda, Daisuke, Chi, SungGi, Uchiyama, Satoshi, Nakamura, Hirotaka, Guo, Yong-Mei, Yamauchi, Nobuhiko, Yuda, Junichiro, Minami, Yosuke
Publicado 2022

Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors

por Atallah, Ehab, Mauro, Michael J., Hochhaus, Andreas, Boquimpani, Carla, Minami, Yosuke, Maheshwari, Vikalp Kumar, Saini, Lovneet, Corbin, Regina, Réa, Delphine
Publicado 2023